Indrayani Biotech Limited (BOM:526445)
India · Delayed Price · Currency is INR 15.94
+0.28 (1.79%)
At close: Nov 7, 2025
Indrayani Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -15.57 | 63.65 | 87.37 | 43.93 | -112.14 | Upgrade |
Depreciation & Amortization | 33.68 | 38.05 | 33.47 | 6.59 | 4.58 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 5 | - | 20.97 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | 0.03 | Upgrade |
Other Operating Activities | 92.88 | 138.9 | 87.18 | 19.11 | 19.65 | Upgrade |
Change in Accounts Receivable | -191.61 | -95.57 | -158.73 | -93.33 | 22.77 | Upgrade |
Change in Inventory | 10.09 | -301.37 | -106.82 | -4.43 | 39.82 | Upgrade |
Change in Accounts Payable | -138.08 | 146.52 | 169.18 | 24.77 | -29.21 | Upgrade |
Change in Other Net Operating Assets | 141.18 | -293.72 | 45.22 | 44.46 | 36.09 | Upgrade |
Operating Cash Flow | -67.42 | -303.54 | 161.88 | 41.11 | 2.56 | Upgrade |
Operating Cash Flow Growth | - | - | 293.76% | 1506.49% | - | Upgrade |
Capital Expenditures | -13.76 | -163.02 | -215.28 | -11.89 | -6.96 | Upgrade |
Sale of Property, Plant & Equipment | 74.67 | 0.66 | - | - | 0.12 | Upgrade |
Cash Acquisitions | - | - | -195.21 | -0.18 | 0.01 | Upgrade |
Investment in Securities | -0.25 | - | -2.23 | - | - | Upgrade |
Other Investing Activities | 180.04 | -1.86 | - | - | - | Upgrade |
Investing Cash Flow | 247.43 | -163.39 | -473.94 | -5.58 | -7.02 | Upgrade |
Long-Term Debt Issued | - | 372.26 | 225.85 | 5.5 | 12.1 | Upgrade |
Long-Term Debt Repaid | -64.3 | -8.48 | -4.63 | -13.69 | - | Upgrade |
Net Debt Issued (Repaid) | -64.3 | 363.78 | 221.22 | -8.19 | 12.1 | Upgrade |
Issuance of Common Stock | - | 46.33 | 232.82 | - | - | Upgrade |
Other Financing Activities | -118.66 | 32.28 | -126.64 | -19.11 | -14.87 | Upgrade |
Financing Cash Flow | -182.95 | 442.39 | 327.39 | -27.3 | -2.77 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | -1.43 | 0 | Upgrade |
Net Cash Flow | -2.94 | -24.55 | 15.33 | 6.8 | -7.23 | Upgrade |
Free Cash Flow | -81.17 | -466.56 | -53.4 | 29.22 | -4.4 | Upgrade |
Free Cash Flow Margin | -6.23% | -28.07% | -3.28% | 4.75% | -2.08% | Upgrade |
Free Cash Flow Per Share | -1.78 | -10.25 | -1.23 | 0.85 | -0.12 | Upgrade |
Cash Interest Paid | - | - | 55.57 | 18.8 | 19.61 | Upgrade |
Levered Free Cash Flow | -524.5 | -478.55 | -301.61 | -31.24 | 21.16 | Upgrade |
Unlevered Free Cash Flow | -457.52 | -416.79 | -270.36 | -19.82 | 33.09 | Upgrade |
Change in Working Capital | -178.42 | -544.14 | -51.14 | -28.53 | 69.47 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.